Authors:
LERAT H
RUMIN S
HABERSETZER F
BERBY F
TRABAUD MA
TREPO C
INCHAUSPE G
Citation: H. Lerat et al., IN-VIVO TROPISM OF HEPATITIS-C VIRUS GENOMIC SEQUENCES IN HEMATOPOIETIC-CELLS - INFLUENCE OF VIRAL LOAD, VIRAL GENOTYPE, AND CELL PHENOTYPE, Blood, 91(10), 1998, pp. 3841-3849
Authors:
ZOULIM F
HAEM J
AHMED SS
CHOSSEGROS P
HABERSETZER F
CHEVALLIER M
BAILLY F
TREPO C
Citation: F. Zoulim et al., RIBAVIRIN MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C - A RETROSPECTIVE STUDY OF 95 PATIENTS, Journal of viral hepatitis, 5(3), 1998, pp. 193-198
Authors:
LANGON T
FILLON S
PICHOUD C
HANTZ O
TREPO C
KAY A
Citation: T. Langon et al., ANALYSIS OF A HEPATITIS-DELTA VIRUS ISOLATE FROM THE CENTRAL-AFRICAN-REPUBLIC, Research in virology (Paris), 149(3), 1998, pp. 171-185
Citation: P. Merle et C. Trepo, ANTIBLASTIC DRUG TARGETING TO HEPATOCELLULAR-CARCINOMA CELLS - A POTENTIAL THERAPEUTIC IMPROVEMENT, The Italian Journal of Gastroenterology, 30(2), 1998, pp. 178-180
Authors:
AGUESSEGERMON S
PICHOUD C
TREPO C
ZOULIM F
Citation: S. Aguessegermon et al., EFFECT OF MUTATIONS IN THE YMDD MOTIF OF THE DHBV REVERSE-TRANSCRIPTASE ON VIRAL REPLICATION CAPACITY AND SENSITIVITY TO NUCLEOSIDE ANALOGS, Hepatology, 28(4), 1998, pp. 294-294
Authors:
LEGUERHIER F
PICHOUD C
CHEVALLIER M
GERMON S
LIU SH
CHEN SH
LI XY
TREPO C
CHENG YC
ZOULIM F
Citation: F. Leguerhier et al., POTENT ANTIVIRAL ACTIVITY OF A NOVEL L-NUCLEOSIDE ANALOG, BETA-L-FD4C, IN THE DUCK HEPATITIS-B VIRUS-INFECTION MODEL, Hepatology, 28(4), 1998, pp. 305-305
Authors:
ROLLIER C
SUNYACH C
BARRAUD L
MADANI N
JAMARD C
TREPO C
COVA L
Citation: C. Rollier et al., PROTECTIVE AND THERAPEUTIC EFFECT OF DNA-BASED IMMUNIZATION AGAINST HEPADNAVIRUS LARGE ENVELOPE PROTEIN, Hepatology, 28(4), 1998, pp. 626-626
Authors:
POYNARD T
MARCELLIN P
LEE S",NIEDERAU,"MINUK G
IDEO G
BAIN V
HEATHCOTE J
ZEUZEM S
TREPO C
ALBRECHT CJ
Citation: T. Poynard et al., A INTERNATIONAL RANDOMIZED TRIAL OF INTERFERON-ALPHA-2B AND RIBAVIRIN(INTRON-A REBETOL) 48 OR 24 WEEKS VS INTRON-A 48 WEEKS FOR FIRST-LINETREATMENT OF CHRONIC HEPATITIS-C/, Hepatology, 28(4), 1998, pp. 900-900
Authors:
GRANDJACQUES C
PRADAT P
STUYVER L
CHEVALLIER M
CHEVALLIER P
PICHOUD C
MAISONNAS M
TREPO C
ZOULIM F
Citation: C. Grandjacques et al., RAPID DETECTION OF MUTATIONS IN THE PROMOTER AND THE PRECORE REGION OF HBV GENOME - CORRELATION WITH VIRAL PERSISTENCE AND DISEASE SEVERITY, Hepatology, 28(4), 1998, pp. 936-936
Citation: Mr. Thursz et al., POLYMORPHISMS IN GENES AFFECTING TH1 TH2 BALANCE INFLUENCE THE OUTCOME OF HBV AND HCV INFECTION/, Hepatology, 28(4), 1998, pp. 1610-1610
Authors:
SEIGNERES B
PICHOUD C
AHMED SS
HANTZ O
TREPO C
ZOULIM F
Citation: B. Seigneres et al., NON RESPONSE TO FAMCICLOVIR THERAPY IN IMMUNE COMPETENT PATIENTS WITHCHRONIC HEPATITIS-B IS ASSOCIATED WITH COMPLEX VARIABILITY OF THE VIRAL POLYMERASE GENE, Hepatology, 28(4), 1998, pp. 1695-1695
Authors:
FOURNILLIER A
NAKANO I
VITVITSKI L
DEFLA E
VIDALIN O
MAERTENS G
TREPO C
INCHAUSPE G
Citation: A. Fournillier et al., MODULATION OF IMMUNE-RESPONSES TO HEPATITIS-C VIRUS ENVELOPE E2 PROTEIN FOLLOWING INJECTION OF PLASMID DNA USING SINGLE OR COMBINED DELIVERY ROUTES, Hepatology, 28(1), 1998, pp. 237-244
Authors:
DUCRET N
MERCIER S
COLIN C
VERGNON P
LAROCHE C
BAILLY F
CAILLETTE A
LABEEUW M
TREPO C
Citation: N. Ducret et al., HEPATITIS-C SCREENING IN CHRONIC-HEMODIAL YSIS PATIENTS IN FRANCE - APHYSICIAN PRACTICE PATTERN STUDY, Nephrologie (Geneve), 19(4), 1998, pp. 217-222
Citation: F. Zoulim et C. Trepo, DRUG-THERAPY FOR CHRONIC HEPATITIS-B - ANTIVIRAL EFFICACY AND INFLUENCE OF HEPATITIS-B VIRUS POLYMERASE MUTATIONS ON THE OUTCOME OF THERAPY, Journal of hepatology, 29(1), 1998, pp. 151-168
Authors:
BIZOLLON TR
RODE A
BANCEL B
GUERIPEL V
DUCERF C
BAULIEUX J
TREPO C
Citation: Tr. Bizollon et al., DIAGNOSTIC-VALUE AND TOLERANCE OF LIPIODOL-COMPUTED TOMOGRAPHY FOR THE DETECTION OF SMALL HEPATOCELLULAR-CARCINOMA - CORRELATION WITH PATHOLOGICAL EXAMINATION OF EXPLANTED LIVERS, Journal of hepatology, 28(3), 1998, pp. 491-496
Authors:
GELAS P
COTTE L
POITEVINLATER F
PICHARD C
LEVERVE X
BARNOUD D
LECLERCQ P
TOURAINEMOULIN F
TREPO C
BOULETREAU P
Citation: P. Gelas et al., EFFECT OF PARENTERAL MEDIUM-CHAIN AND LONG-CHAIN TRIGLYCERIDES ON LYMPHOCYTES SUBPOPULATIONS AND FUNCTIONS IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME - A PROSPECTIVE-STUDY, JPEN. Journal of parenteral and enteral nutrition, 22(2), 1998, pp. 67-71
Authors:
POYNARD T
MARCELLIN P
LEE SS
NIEDERAU C
MINUK GS
IDEO G
BAIN V
HEATHCOTE J
ZEUZEM S
TREPO C
ALBRECHT J
Citation: T. Poynard et al., RANDOMIZED TRIAL OF INTERFERON-ALPHA-2B PLUS RIBAVIRIN FOR 48 WEEKS OR FOR 24 WEEKS VERSUS INTERFERON-ALPHA-2B PLUS PLACEBO FOR 48 WEEKS FOR TREATMENT OF CHRONIC INFECTION WITH HEPATITIS-C VIRUS, Lancet, 352(9138), 1998, pp. 1426-1432
Authors:
AGUESSEGERMON S
LIU SH
CHEVALLIER M
PICHOUD C
JAMARD C
BOREL C
CHU CK
TREPO C
CHENG YG
ZOULIM F
Citation: S. Aguessegermon et al., INHIBITORY EFFECT OF 2'-FLUORO-5-METHYL-BETA-L-ARABINOFURANOSYL-URACIL ON DUCK HEPATITIS-B VIRUS-REPLICATION, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 369-376
Authors:
HABERSETZER F
FOURNILLIER A
DUBUISSON J
ROSA D
ABRIGNANI S
WYCHOWSKI C
NAKANO I
TREPO C
DESGRANGES C
INCHAUSPE G
Citation: F. Habersetzer et al., CHARACTERIZATION OF HUMAN MONOCLONAL-ANTIBODIES SPECIFIC TO THE HEPATITIS-C VIRUS GLYCOPROTEIN E2 WITH IN-VITRO BINDING NEUTRALIZATION PROPERTIES, Virology (New York, N.Y. Print), 249(1), 1998, pp. 32-41